HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Kato Selected Research

Mycoplasma Pneumonia

2/2021Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children.
10/2017Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
8/2013Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Kato Research Topics

Disease

57Neoplasms (Cancer)
05/2022 - 01/2002
40Nasal Polyps (Nasal Polyp)
11/2022 - 06/2008
38Rhinosinusitis
11/2022 - 06/2008
26Inflammation (Inflammations)
01/2022 - 04/2002
20Infections
02/2021 - 12/2002
18Pancreatic Neoplasms (Pancreatic Cancer)
10/2019 - 10/2004
14Neoplasm Metastasis (Metastasis)
04/2022 - 05/2003
14Asthma (Bronchial Asthma)
01/2022 - 10/2004
11Virus Diseases (Viral Diseases)
05/2022 - 06/2002
10Ischemia
11/2016 - 04/2002
9Gaucher Disease (Gaucher's Disease)
08/2022 - 12/2006
9Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2019 - 01/2002
9Cholangiocarcinoma
11/2017 - 01/2004
9Hepatocellular Carcinoma (Hepatoma)
09/2016 - 05/2003
7Polyps
11/2022 - 01/2010
7Pathologic Constriction (Stenosis)
02/2017 - 07/2008
7Klatskin Tumor
12/2014 - 04/2005
7Obstructive Jaundice (Cholestatic Jaundice)
06/2014 - 04/2005
6Carcinoma (Carcinomatosis)
01/2017 - 10/2004
6Reperfusion Injury
03/2011 - 04/2002
5Thrombosis (Thrombus)
07/2017 - 11/2007
5Head and Neck Neoplasms (Head and Neck Cancer)
05/2017 - 11/2014
5Edema (Dropsy)
11/2014 - 03/2004
5Hyperglycemia
02/2014 - 09/2008
4Hypersensitivity (Allergy)
01/2022 - 05/2009
4Hemorrhage
01/2018 - 01/2005
4Eosinophilia
11/2017 - 04/2015
4Ascites
02/2017 - 11/2006
3Pneumonia (Pneumonitis)
02/2021 - 05/2013
3Mycoplasma Pneumonia
02/2021 - 08/2013
3Hyperbilirubinemia
02/2019 - 06/2014
3Sigmoid Neoplasms
02/2019 - 11/2007
3Thrombocytopenia (Thrombopenia)
02/2019 - 04/2003
3Lymphatic Metastasis
11/2017 - 11/2015
3Type 2 Diabetes Mellitus (MODY)
01/2017 - 01/2011
3Heart Failure
09/2016 - 02/2015
3Adenocarcinoma
04/2016 - 06/2009
3Fever (Fevers)
11/2015 - 05/2013
3Cholangitis
11/2015 - 05/2010
3Liver Failure
06/2014 - 10/2004
3Hypertrophy
06/2014 - 08/2004
3Hyperalgesia
07/2009 - 03/2009

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2002
19CytokinesIBA
05/2022 - 03/2004
16Messenger RNA (mRNA)IBA
01/2017 - 05/2003
10GemcitabineFDA Link
11/2017 - 08/2007
8GlucosidasesIBA
08/2022 - 12/2012
8EnzymesIBA
08/2021 - 01/2016
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 02/2013
7Interleukin-13IBA
11/2022 - 02/2003
7Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2015
7Anti-Bacterial Agents (Antibiotics)IBA
02/2021 - 05/2009
7Interleukin-6 (Interleukin 6)IBA
01/2018 - 06/2004
6Biological ProductsIBA
05/2022 - 07/2008
6AntibodiesIBA
07/2017 - 04/2003
5Interleukin-5 (Interleukin 5)IBA
11/2022 - 04/2015
5Antiviral Agents (Antivirals)IBA
01/2021 - 09/2005
5Thymic Stromal LymphopoietinIBA
01/2020 - 07/2007
5Cisplatin (Platino)FDA LinkGeneric
11/2017 - 05/2005
5AntigensIBA
04/2013 - 06/2002
4Glycoside Hydrolases (Endoglycosidases)IBA
05/2022 - 03/2005
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2004
4Immunoglobulin G (IgG)IBA
01/2022 - 12/2011
4MacrolidesIBA
02/2021 - 05/2013
4Immunoglobulin E (IgE)IBA
01/2021 - 11/2009
4Glucosylceramidase (Glucocerebrosidase)IBA
04/2020 - 12/2006
4Glucose (Dextrose)FDA LinkGeneric
12/2019 - 06/2010
4MucinsIBA
11/2019 - 05/2010
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2019 - 03/2009
4ChemokinesIBA
07/2011 - 11/2009
3Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2022 - 09/2005
3FibrinIBA
11/2022 - 01/2013
3Indicators and Reagents (Reagents)IBA
04/2022 - 11/2008
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 02/2010
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 10/2004
3Peroxidase (Myeloperoxidase)IBA
11/2019 - 03/2004
3Tumor Biomarkers (Tumor Markers)IBA
02/2019 - 11/2014
3LigandsIBA
01/2018 - 01/2012
3Small Interfering RNA (siRNA)IBA
11/2017 - 11/2008
3Pharmaceutical PreparationsIBA
01/2017 - 03/2005
3Peptide Hydrolases (Proteases)FDA Link
04/2016 - 11/2009
3Interferon Type IIBA
08/2015 - 09/2008
3B-Cell Activating FactorIBA
10/2012 - 06/2008
3Interleukin-1 (Interleukin 1)IBA
07/2012 - 11/2002
3Interleukin-10 (Interleukin 10)IBA
03/2009 - 02/2003
3NF-kappa B (NF-kB)IBA
10/2004 - 07/2002
2Plasminogen Activators (Plasminogen Activator)IBA
11/2022 - 01/2015
2fibrin fragment D (D-dimer)IBA
11/2022 - 11/2016

Therapy/Procedure

23Hepatectomy
04/2022 - 01/2004
20Drug Therapy (Chemotherapy)
10/2019 - 11/2004
19Therapeutics
10/2022 - 10/2004
14Pancreaticoduodenectomy
05/2017 - 03/2006
11Pancreatectomy
06/2019 - 10/2004
9Stents
11/2022 - 11/2006
7Operative Surgical Procedures
09/2017 - 01/2002
4Neoadjuvant Therapy
06/2019 - 10/2012
3Splenectomy
01/2018 - 10/2003
3Segmental Mastectomy (Lumpectomy)
11/2015 - 11/2007
3Liver Transplantation
01/2014 - 07/2005
3Adjuvant Chemotherapy
12/2012 - 11/2008